NAD+ for Women After 45: What the Cellular Science Actually Shows

Somewhere around 45, a lot of women start noticing the same handful of things at once. The brain fog that shows up mid-sentence.

The sleep that used to reset you and now just... doesn't. The recovery time after a hard week that used to be a day and is now closer to three.

Most wellness content will tell you this is about "boosting your energy." We're not going to tell you that.

Not because it isn't a real experience, it clearly is, but because "energy boost" isn't an honest description of what's actually happening inside your cells, and this brand exists specifically because we're tired of watching that phrase get used to sell things it can't deliver.

So here's what the research actually says, in plain language, including the parts that are still genuinely unresolved.

The Science, Explained Honestly

The Cell You've Never Thought About: Your Ovaries Are Aging Faster Than You Are

 

Most people assume aging happens gradually and evenly across the body. Ovarian tissue doesn't play by that rule.

Research on reproductive aging has found that the ovary shows measurable signs of cellular aging earlier and more sharply than most other organs, well before menopause itself arrives, with menopause typically occurring around age 50–52, decades before the rest of the body shows comparable wear.

The question scientists have been chasing is why the ovary ages on a faster clock. A team at the Buck Institute, traced part of the answer to a single enzyme: CD38.

Meet CD38: The Enzyme Quietly Draining Your NAD+

CD38 is a protein that breaks down NAD+, the molecule your cells depend on for basic maintenance, DNA repair, and stress recovery.

As we age, CD38 activity increases in ovarian tissue, and it does something specific: it consumes NAD+ faster than the body can replace it. According to the Nature Aging study, earlier-onset inflammation drives higher CD38 expression and lower NAD+ levels in the ovary, which in turn accelerates ovarian aging.

In mouse studies, researchers were able to test this mechanism directly. When they removed CD38 from mice genetically, the effect was notable: those mice maintained a larger reserve of ovarian follicles and had better fertility outcomes than mice with normal CD38 activity. When researchers used a drug to block CD38 pharmacologically in middle-aged mice, fertility improved as well, according to the same Nature Aging research.

Here's the honest caveat, because that's the whole point of this brand: this is mouse research. It tells us CD38 is a real, targetable mechanism behind ovarian NAD+ decline — that part is well-established.

It does not tell us exactly how this translates to human dosing, timelines, or outcomes. Anyone who tells you it does is skipping a step the scientists themselves haven't taken yet.

Why This Isn't Just About Fertility

It would be easy to file this under "reproductive biology" and move on, but the researchers behind this work have been explicit that the implications reach further.

Buck Institute President Dr. Eric Verdin, senior author on the CD38 study, explained in a Buck Institute release that understanding the processes linking reproductive aging to menopause connects directly to the overall lifespan and health span of women, not just fertility, but the whole-body experience of aging.

That framing matters, because it lines up with something else the research shows:

 

The Compounding Effect: Two Systems Losing Ground at Once

Estrogen isn't just a reproductive hormone. It's directly involved in how your cells generate and manage energy at the mitochondrial level.

Research on estrogen and brain metabolism during perimenopause has shown that during this transition, estrogen's regulation of glucose metabolism in the brain starts to falter, producing a hypometabolic state accompanied by measurably reduced mitochondrial function.

This isn't a fringe finding, it's been observed consistently enough that researchers describe perimenopause as inducing a distinct shift in how the brain and body generate cellular energy, sustained well past the transition itself.

Put the two mechanisms side by side and you get a clearer, more honest picture of what's actually happening between 45 and 55:

🧬NAD+ decline accelerated by rising CD38 activity reduces the raw material your cells need for repair and maintenance.

📉Estrogen decline simultaneously reduces how efficiently your cells can use the energy-producing machinery they still have.

Neither of these is "just in your head," and neither of them is solved by the word "energy boost" on a supplement label. They're two separate biological systems losing ground during the same five-to-ten-year window, which is very likely part of why this period can feel so disproportionately hard compared to how it's usually talked about.

What NAD+ Actually Does Without the Overclaim

NAD+ isn't a stimulant, and it isn't fuel in the way sugar or caffeine are. Its job is closer to cellular maintenance staff. It's required by two families of proteins that matter a great deal as we age:

✅Sirtuins, which regulate cellular stress response, inflammation, and long-term repair processes

✅PARPs, which use NAD+ to fix damaged DNA before that damage accumulates into dysfunction

As NAD+ availability drops, these maintenance systems have less to work with. That's a real, well-supported mechanism. What's not well-supported, and what we won't pretend is settled, is a precise claim about how much NAD+, in what form, at what dose, reverses or meaningfully slows this in humans over months or years. 

What This Actually Feels Like (Because the Science Isn't the Whole Story)

Ask any community of women in their late 40s and 50s what this decade feels like, and the science above tracks almost exactly onto what they describe, usually before anyone hands them a mechanism to explain it.

The mid-afternoon flatness that has nothing to do with how much sleep they got. The recovery from a bad night that used to take one day and now genuinely takes three.

The moment of forgetting a word mid-sentence that has nothing to do with memory loss and everything to do with a brain running on a different metabolic budget than it used to.

None of that is dramatic. None of it is a crisis. It's cellular resilience, the capacity to absorb stress, repair, and bounce back, quietly declining on two fronts at once. Naming it accurately doesn't fix it, but it does mean you can stop wondering if you're imagining it.